These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15234275)

  • 21. Pharmacological approaches to reducing the risk of prostate cancer.
    Rittmaster RS; Fleshner NE; Thompson IM
    Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells.
    Nair S; Li W; Kong AN
    Acta Pharmacol Sin; 2007 Apr; 28(4):459-72. PubMed ID: 17376285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF-kappa B and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities.
    Surh YJ
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():269-72. PubMed ID: 18296353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoprevention of prostate cancer.
    Brand TC; Canby-Hagino ED; Pratap Kumar A; Ghosh R; Leach RJ; Thompson IM
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):831-43. PubMed ID: 16861117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men.
    Sarma AV; McLaughlin JC; Wallner LP; Dunn RL; Cooney KA; Schottenfeld D; Montie JE; Wei JT
    J Urol; 2006 Sep; 176(3):1108-13. PubMed ID: 16890703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-course study of cellular immune response and testosterone metabolism in an autoimmune model for chronic prostatic inflammation.
    Donadio AC; Gagliano H; Remedi MM; Nowotny E; Depiante-Depaoli M
    J Urol; 1998 Oct; 160(4):1546-50. PubMed ID: 9751410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: preventive effects of celecoxib.
    Narayanan NK; Nargi D; Horton L; Reddy BS; Bosland MC; Narayanan BA
    Prostate; 2009 Feb; 69(2):133-41. PubMed ID: 18819100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate carcinogenesis and inflammation: emerging insights.
    Palapattu GS; Sutcliffe S; Bastian PJ; Platz EA; De Marzo AM; Isaacs WB; Nelson WG
    Carcinogenesis; 2005 Jul; 26(7):1170-81. PubMed ID: 15498784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quantitative changes of testosterone and prostate-specific antigen at low and high densities of PSA in men with prostate cancer].
    Khuskivadze AA; Kochiashvili DK
    Georgian Med News; 2007 Feb; (143):67-9. PubMed ID: 17404444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver.
    Singh PB; Matanhelia SS; Martin FL
    Eur J Cancer; 2008 May; 44(7):928-36. PubMed ID: 18381236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio.
    Yatkin E; Bernoulli J; Talvitie EM; Santti R
    Int J Androl; 2009 Aug; 32(4):399-410. PubMed ID: 19515173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local inflammation influences oestrogen metabolism in prostatic tissue.
    Mosli HA; Al-Abd AM; El-Shaer MA; Khedr A; Gazzaz FS; Abdel-Naim AB
    BJU Int; 2012 Jul; 110(2):274-82. PubMed ID: 22145816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of prostate cancer. Part 1: chemoprevention.
    Sooriakumaran P
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):419-25. PubMed ID: 16503858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High selenium reduces NF-kappaB-regulated gene expression in uninduced human prostate cancer cells.
    Christensen MJ; Nartey ET; Hada AL; Legg RL; Barzee BR
    Nutr Cancer; 2007; 58(2):197-204. PubMed ID: 17640166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer chemoprevention: current status and future prospects.
    Gupta S
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysosomal and prostasomal hydrolytic enzymes and redox processes and initiation of prostate cancer.
    Tappel A
    Med Hypotheses; 2005; 64(6):1170-2. PubMed ID: 15823710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer.
    Sutcliffe S; Giovannucci E; De Marzo AM; Leitzmann MF; Willett WC; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2160-6. PubMed ID: 17119041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of estrogens in development of prostate cancer.
    Härkönen PL; Mäkelä SI
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):297-305. PubMed ID: 15663993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.